Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antiparasitics

Set Alert for Antiparasitics

US survey highlights growing appetite for Seresto in antiparasitic battleground

A new survey of US veterinarians has further underlined Seresto's place among leading the leading pet antiparasitics.

Markets Companion Animals

Benchmark raises significant funds to support commercial efforts

UK aquaculture health business Benchmark has raised proceeds of £43 million ($56 million) to scale up and launch new technologies.

Aquaculture Operations

Elanco prepares sale of European pet wormer rights to Vetoquinol

Elanco has moved a step closer to completing its acquisition of Bayer Animal Health by agreeing its third divestment deal to satisfy anti-trust regulators.

Europe Elanco

Review 2019: US witnesses bumper year of veterinary approvals, while EU achieves milestone authorizations

In 2019, both the US and Europe saw several significant approvals in animal health. Animal Pharm analyst Sian Lazell gives an overview of the most notable products that were given the green light for their commercial debuts during the year.

Product Approvals Companion Animals

MSD adds canine mites to Bravecto label in Europe

MSD Animal Health has further built on the label of Bravecto (fluralaner) in Europe, with the product now approved to treat mite infestations in dogs.

Merck MSD Animal Health Canine

Animal Pharm Awards 2019 now open for nominations

Subscribers have five weeks to nominate their company and innovations as part of the Animal Pharm Awards for 2019.

Europe North America

Merck gets further Bravecto Plus boost with US approval for cats

Merck Animal Health's Bravecto Plus topical solution can now be used for cats in the US following FDA approval.

United States Product Approvals

Boehringer boosts manufacturing footprint with Puerto Rico expansion

Boehringer Ingelheim Animal Health has invested nearly $50 million in the extension of its manufacturing site in Barceloneta, Puerto Rico. 

Boehringer Ingelheim Animal Health Operations

Merck confirms development of triple combo antiparasitic

Merck Animal Health is currently working on the development of a triple-action antiparasitic for pets – a potential blockbuster product.

Merck MSD Animal Health Companion Animals

Alivira API facility gets WHO anthelmintic accreditation

Alivira Animal Health has gained WHO-Geneva approval for the manufacture of praziquantel-based anthelmintics at its facility in Vizag.

Alivira Animal Health Antiparasitics

Elanco handed supplemental approval for Credelio tablets

Elanco has received a supplemental approval from the US FDA for its Credelio antiparasitic that adds a preventative indication to the product.

Elanco Antiparasitics

MSD study reveals parasiticide impact on poultry red mite infestations

A new study by MSD Animal Health has highlighted new data on the impact of Exzolt – a parasiticide for poultry red mite infestations.

Merck MSD Animal Health Antiparasitics
See All
UsernamePublicRestriction

Register